Gavin Bushell is a partner in the European & competition law practice group in Brussels, where he advises clients on EU competition, state aid and aviation law. He has more than 10 years of experience practicing law and is a frequent speaker at legal conferences, particularly on aviation matters. He is chairman of the Law Society, Brussels Section, and co-author of a number of articles on EU competition law. He is also a member of various legal and industry associations such as the European Air Law Association, the European Nuclear Energy Forum, the World Nuclear Association and the European Aviation Club. In March 2012, Gavin Bushell was named by Global Competition Review as one of the top 40 of the world’s leading competition practitioners under the age of 40 in its 40 under 40 survey. Gavin Bushell focuses on EU competition and state aid law, EU merger control law and aviation law and regulation, and has acted for global companies in various sectors including aviation, banking, beverages, mining, recorded music, manufacturing, packaging and nuclear energy. He has broad experience in all aspects of merger transactions, international cartel and horizontal agreement investigations, state aid proceedings, Article 102 TFEU (abuse of dominance) investigations as well as representing clients in litigation before the General Court of the European Court of Justice in Luxembourg to challenge European Commission decisions. Gavin Bushell has advised and trained clients around the world on creating and implementing competition compliance training programmes.
368
In brief On 5 May 2021, the European Commission ("Commission") published a proposed Regulation, along with an impact assessment report, aiming to address potential distortions caused by foreign subsidies in the Single Market ("Proposed Regulation"). This Proposed Regulation will create (...)
267
EU Merger Control and Implications from the Effects of the Coronavirus Crisis* The global coronavirus pandemic impacts all aspects of life. The operation of the EU merger control regime is no exception. This situation will likely continue for some considerable period, potentially over (...)
948
This article has been nominated for the 2016 Antitrust Writing Awards. Click here to learn more about the Antitrust Writing Awards. Veering off the well-trodden path? European Merger Control and the Pharmaceutical Indutry* We have recently celebrated the 25th anniversary of the EU Merger (...)
188
Still in primary containment: the European Commission’s approach to State aid in the nuclear industry* On 8 October 2013, it was announced that the nuclear industry would not be included in the European Commission’s draft Guidelines on environmental and energy aid for 2014-2020 as anticipated. (...)
515
Minority Report? The EC’s public consultation on minority shareholdings* On 25 June 2013, the European Commission launched a public consultation entitled “Towards more effective EU Merger Control” in which the Commission proposes to (i) expand its powers to review non-controlling minority (...)
244
The one-handed European Merger Simplification Project?* Like the European Commission, I am confident that the European Merger Simplification Project will bring benefits for clients. As many commentators have affirmed, I do not doubt that the increase of the currently applicable market share (...)
1276
Clear roads ahead? Judgment on selective distribution systems from the European Court of Justice* In a judgment handed down on June 14, 2012 (C-158/11 Auto 24), the EU Court of Justice (“CJEU”) confirmed that suppliers operating selective distribution systems (“SDSs”) are under no obligation to (...)
470
AstraZeneca v Commission, Advocate-General Mazak’s Opinion of 15 May 2012* On 15 May 2012, Advocate-General Mazák delivered his long awaited Opinion to the European Court of Justice in the long-running AstraZeneca litigation. Practitioners hoping for an opinion that tempered some of the more (...)
Price
€270.00
Competition Law Treatment of Joint Ventures
19 avenue Jean Aicard
75011 Paris, France
106 West 32nd Street, Suite 149
New York, NY, 10001, USA
563 Chiswick High Road
W4 3AY London, UK
